13D Management LLC - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 167 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.20 and the average weighting 0.2%.

Quarter-by-quarter ownership
13D Management LLC ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$330,319
-93.9%
34,301
-93.3%
0.20%
-93.1%
Q2 2023$5,438,178
-3.1%
511,107
-4.2%
2.97%
+4.1%
Q1 2023$5,613,073
-15.1%
533,5620.0%2.85%
-18.0%
Q4 2022$6,610,833
+6.3%
533,562
-11.1%
3.48%
+6.8%
Q3 2022$6,220,000
-10.2%
600,4310.0%3.26%
+6.3%
Q2 2022$6,923,000
-2.3%
600,431
+6.6%
3.06%
+13.6%
Q1 2022$7,084,000
-0.9%
563,103
-8.1%
2.70%
-1.6%
Q4 2021$7,146,000
-15.9%
612,853
-5.8%
2.74%
-13.3%
Q3 2021$8,494,000
+1.5%
650,4550.0%3.16%
+9.8%
Q2 2021$8,371,000
+13.8%
650,455
-1.1%
2.88%
+5.7%
Q1 2021$7,357,000
+74.3%
658,017
+77.6%
2.72%
+56.2%
Q4 2020$4,220,000
+7.5%
370,435
-15.1%
1.74%
+0.9%
Q3 2020$3,925,000
-11.7%
436,322
+1.3%
1.73%
-10.6%
Q2 2020$4,444,000
-1.7%
430,644
-3.9%
1.93%
-12.0%
Q1 2020$4,520,000
-19.3%
447,968
+6.5%
2.20%
+29.2%
Q4 2019$5,600,000
+27.2%
420,753
-18.0%
1.70%
+17.5%
Q3 2019$4,403,000
-17.8%
512,915
+4.8%
1.45%
-10.3%
Q2 2019$5,355,000489,5301.61%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Sarissa Capital Management LP 16,390,000$157,835,70021.26%
AlphaCentric Advisors LLC 292,500$2,816,7751.60%
Quantedge Capital Pte Ltd 179,900$1,732,4370.94%
Intrinsic Value Partners, LLC 50,355$484,9190.62%
Brown Capital Management 3,719,796$35,821,6350.55%
ARMISTICE CAPITAL, LLC 3,456,000$33,281,2800.51%
SummerHaven Investment Management, LLC 67,765$652,5770.48%
BRAIDWELL LP 1,348,099$12,982,1930.41%
AFFINITY INVESTMENT ADVISORS, LLC 50,733$488,5590.32%
EMC Capital Management 43,315$4170.31%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders